Lymph Node Mapping
Sponsors
Gynecologic Oncology Group, M.D. Anderson Cancer Center, Jeroen Bosch Ziekenhuis, Case Comprehensive Cancer Center, Cardinal Health 414, LLC
Conditions
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedColorectal CancerEndometrial Clear Cell AdenocarcinomaEndometrial Mixed AdenocarcinomaEndometrial Serous Adenocarcinoma
Phase 2
Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid
CompletedNCT00832429
Start: 2009-02-25End: 2024-08-27Updated: 2025-07-04
Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery
NCT01097265
Start: 2010-07-31Target: 1500Updated: 2013-08-12
A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping
CompletedNCT02509598
Start: 2015-08-31End: 2019-03-06Updated: 2024-06-28
Unknown Phase
Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
TerminatedNCT00070317
Start: 2004-06-30End: 2013-01-31Updated: 2017-11-06
Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer
TerminatedNCT01048853
Start: 2010-04-15End: 2025-12-05Updated: 2026-01-07
PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer
Active, not recruitingNCT01737619
Start: 2013-04-03End: 2025-12-31Updated: 2025-11-28
Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery
TerminatedNCT01939028
Start: 2013-07-31End: 2016-10-31Updated: 2020-08-27
Prediction of Recurrence Among Low Risk Endometrial Cancer Patients
Active, not recruitingNCT04604613
Start: 2012-11-08End: 2026-12-31Updated: 2026-03-09